FrancophonIA/ELRC3.0 huggingface dataset:
English: The continuing responsibility for the organisation and support of the Veterinary Joint Implementation Group, the coordination of training, and the management of registration applications for access to EudraVigilance, as well as data collection, analysis, reporting and communication of electronic adverse reactions received from 1 January 2005, will place significant burdens on the small pharmacovigilance group in the veterinary sector.
Maltese: Implimentazzjoni, il-koordinazzjoni ta' taħriġ, il-ġestjoni ta' applikazzjonijiet ta' reġistrazzjoni għal aċċess għall-EudraVigilance, kif ukoll ġbir tad-data, analiżi, rappurtaġġ u komunikazzjoni ta' reazzjonijiet mhux mixtieqa riċevuti elettronikament mill-1 ta' Jannar 2005, iqiegħdu tagħbijiet sinifikanti fuq il-grupp żgħir ta' farmakoviġilanza fis-settur veterinarju.
English: He currently holds the positions of director and professor at the Federal Institute for Drugs and Medical Devices.
Maltese: Fil-preżent jokkupa l-pożizzjoni ta' Direttur u Professur fl-Istitut Federali għall-Mediċini u Strumenti Mediċi.
English: Between 1974 and 1996 he held posts in the UK Medicines Division and the Medicines Control Agency, including those of inspector of pharmaceutical manufacture, reviewer of dossiers, and manager of the biotechnology and biological unit.
Maltese: 1974 u l-1996, okkupa karigi fid-Diviżjoni tal-Mediċina tar-Renju Unit u fl-Aġenzija għall-Kontroll tal-Mediċini, bħala spettur tal-manifattura farmaċewtika, reviżur ta' applikazzjonijiet u kap ta' l-Unità tal-Bijoteknoloġija u Bijoloġija.
English: Arbitration and Community referrals made to EMEA (Input)
Maltese: L-Arbitragg u referenzi Komunitarji maghmula lillEMEA (Dehlin)
English: A wide range of documents are published by the EMEA, including press releases, general information documents, annual reports and work programmes.
Maltese: Servizzi ta' dokumentazzjoni L-EMEA tippubblika firxa wiesgħa ta' dokumenti li jinkludu stqarrijiet għall-istampa, dokumenti ta'
English: The ad hoc group of GCP inspection services will meet four times in 2005.
Maltese: Il-grupp ad hoc ta' servizzi ta' spezzjoni tal-GCP jiltaqa' erba' darbiet fl-2005.
English: Impact of Process Analytical Technologies on quality aspects of assessment and inspection
Maltese: Concept paper on impact of analytical methods on Commission Decision
English: Career to date: From 1988 to 1992, Dr Brosch worked as an assistant professor at the department of pharmacology and toxicology at the University of Vienna, where she specialised in electrophysiology.
Maltese: Brosch ħadment bħala assistent professur fidDipatiment tal-Farmakoloġija u tat-Tossikoloġija fl-Università ta' Vjenna, fejn speċjalizzat flelettrofiżjoloġija.
English: Concept paper to be transmitted to CHMP by Q2 2005
Maltese: Id-Dokument dwar Kunċetti għandu jiġi żviluppat f'2005
English: The COMP ad hoc biotechnology group will support the designation process for emerging therapies, and the COMP group with interested parties will continue its activities on a regular basis
Maltese: Il-Grupp ad hoc tal-COMP dwar il-bijoteknoloġija jappoġġa l-proċess ta' ikklassifikar għal terapiji li qegħdin jitfaċċaw, u l-Grupp tal-COMP ma' partijiet interessati ikompli l-attivitajiet tiegħu fuq bażi regolari
English: Since October 2004 she has been in charge of establishing the new sector for medical information.
Maltese: Ilha minn Ottubru ta' l-2004 inkarigata mit-twaqqif tasSettur il-ġdid għall-informazzjoni medika.
English: MRLs new applications MRL ext./mod.
Maltese: Applikazzjonijiet ghal estensjoni/modifika ta' MRL Applikazzjonijiet godda ghal MRL
English: To implement EudraVigilance Veterinary effectively on 1 January 2005 for the competent authorities and by November 2005 for the Veterinary pharmaceutical industry
Maltese: L-Implimentazzjoni tal-EudraVigilance Veterinary b'mod effettiv fl-1 ta' Jannar 2005 għall awtoritajiet kompetenti u sa Novembru 2005 għall-industrija farmaċewtika veterinarja L-Inkoraġġiment ta' skambju ikbar ta' informazzjoni u djalogu dwar attivitajiet ta' wara lawtorizzazzjoni u s-sigurtà ta' mediċini, u l-kontribuzzjoni għall-utilizzazzjoni effettiva ta'
English: Under development by SWP-V
Maltese: Qegħdin jiġu żviluppati mill-SWP-V
English: He was re-elected chairman of the CHMP in 2004.
Maltese: Reġa' inħatar president tal-CHMP fl-2004.
English: 1.6 EU institutions, agencies and international partners
Maltese: 1.6 Istituzzjonijiet ta' l-UE, aġenziji u msieħba internazzjonali
English: He joined the EMEA in May 1996 and was appointed head of sector for regulatory affairs and operational support in January 2001.
Maltese: Ingħaqad ma' lEMEA f'Mejju ta' l-1996 u inħatar Kap tas-Settur għall-affarijiet regolatorji u sostenn ta' l organizzazzjoni f'Jannar ta' l-2001.
English: Arbitration and Community referrals received/forecast (Input)
Maltese: Talbiet ghal pariri xjentifici ricevuti/mbassra (Dehlin)
English: Pharmacovigilance Working Party
Maltese: Pharmacovigilance Information
English: He served on the management board of the French National Agency for Health Evaluation and Hospital Accreditation (ANAES) from 2000 to 2004, and on its executive committee from 2002 to 2004.
Maltese: Saħħa u Akkreditar ta' l-Isptarijiet (ANAES) mill-2000 sa l-2004, u fil-Kumitat Eżekuttiv tagħha mill2002 sa l-2004.
English: He is a co-founder of the European Organisation for Rare Diseases (EURORDIS) of which he has been the chief executive officer since 2001.
Maltese: Huwa ko-fondatur ta' l-Organizzazzjoni Ewropea għal Mard Rari (EURORDIS) li tagħha ilu Kap Uffiċjal Eżekuttiv mill-2001.
English: The EMEA checks compliance of such products distributed in parallel with the appropriate terms of the Community marketing authorisation.
Maltese: L-EMEA tikkontrolla l konformità ta' dawn il-prodotti mqassma b'mod parallel mat-termini approprjati ta' l-awtorizzazzjoni
English: Deadline for comments March
Maltese: Introduzzjoni mid-Direttur Eżekuttiv
English: To conduct quality assessments of MRL applications and related activities, and adhere to regulatory timelines
Maltese: It-twettieq ta' ikklassifikar ta' kwalità għal prodotti mediċinali ltiema u attivitajiet relatati u l osservanza tal-limiti ta' żmien regolatorji
English: Parallel distribution
Maltese: armonizzazzjoni globali
English: Type I variations continue to grow in line with total marketing authorisations, with 25 anticipated for 2005.
Maltese: Varjazzjonijiet tat-Tip I ikomplu jikbru in linja man-numru totali ta' l-awtorizzazzjonijiet għal tqegħid fis-suq, b'25 mistennija fl-2005.
English: She worked for the pharmaceutical industry from 1992 to 1995 before joining the EMEA in July 1995.
Maltese: Ħadmet fl-industrija farmaċewtika mill-1992 sa l-1995 qabel ma ngħaqdet ma' l-EMEA f'Lulju ta' l-1995.
English: Melanie Leivers, Deputy Head of Sector for veterinary marketing authorisation procedures, b. 1 December 1958, n. British
Maltese: Veterinarja għal Tqegħid fis-Suq, twieldet fl-1 ta' Diċembru 1958, ċittadinanza Britannika
English: Continued implementation and maintenance of the electronic transmission of ICSRs and support of the day-to-day operation and maintenance of the electronic ICSR transmission process for the pre- and post-authorisation phase via EudraVigilance
Maltese: L-Implimentazzjoni u manutenzjoni kontinwa tat-trasmissjoni elettronika ta' ICSR u sostenn għall-operazzjoni minn jum għall-ieħor u l-manutenzjoni tal-proċess ta' trasmissjoni elettronika ICSR għall-fażi ta' qabel u wara l-awtorizzazzjoni permezz ta' l-EudraVigilance
English: These initiatives include implementation of the concept of risk management plans, expansion of the scope of medicines to be authorised through the centralised procedure, establishment of the accelerated assessment, conditional authorisation and compassionate use procedures, as well as procedures for authorisation of biosimilar and generic products, and support to small and medium-sized enterprises 9 High importance will be attributed to initiatives aimed at increased communication and provision of information to patients, healthcare professionals and the general public
Maltese: pjanijiet għall-ġestjoni tar-riskju, l-espanzjoni tal-qasam ta' applikazzjoni ta' mediċini li għandhom jiġu awtorizzati permezz tal-proċedura ċentralizzata, it-twaqqif ta' proċeduri għal valutazzjoni mgħaġġla, awtorizzazzjoni kondizzjonali w użu kompassjonali, kif ukoll proċeduri għall-awtorizzazzjoni ta' prodotti bijosimili u ġeneriċi, u sostenn lil intrapriżi żgħar u ta' daqs medju.
English: Applications received (non-orphan medicines) Applications received (orphan medicines)
Maltese: Applikazzjonijiet ricevuti (medicini mhux ltiema) Applikazzjonijiet ricevuti (medicini ltiema)
English: CVMP meetings in 2005
Maltese: Fl-2005
English: Education: Professor Wahlroos is a qualified pharmacist (pharmacology) from the University of Helsinki and holds a PhD (SocPharm) from the University of Kuopio.
Maltese: Wahlroos huwa spiżjar (kwalifikat fil-farmakoloġija) mħarreġ fl-Università ta'
English: Work with the Agency's traditional partners on the EU-Japan-USA trilateral harmonisation of regulatory requirements for human and veterinary medicines (ICH and VICH)
Maltese: il-Ġappun u l-Istati Uniti ta' l-Amerika, ta' ħtiġijiet regolatorji għal mediċini għal użu talbniedem u veterinarji (ICH u VICH)
English: Dr Korteweg joined the EMEA in August 1997 and has acted as EMEA quality manager since July 1998.
Maltese: 1997 u okkupat il-kariga ta' kap tal-kwalità ta' l-EMEA minn Lulju ta' l-1998.
English: 31 May - 1 June
Maltese: 31 ta' Mejju - 1 ta' Ġunju
English: 22-23 March
Maltese: 22-23 ta' Marzu
English: Revision to be finalised in 3/4Q 2005
Maltese: Għandu jiġi ffinalizzat fit-tieni kwart ta' l-2005
English: To handle effectively and in a timely manner adverse reaction reports and PSURs for centralised products, in conjunction with rapporteur and co-rapporteur, for review by the CVMP, and to communicate information to the Commission, the Member States and the general public
Maltese: It-trattament b'mod effettiv u f'waqtu, flimkien mar-rapportatur u l-ko-rapportatur, ta' rapporti dwar reazzjonijiet mhux mixtieqa u PSUR għal prodotti ċentralizzati li għandhom jiġu riveduti mill-CVMP, u l-komunikazzjoni ta' informazzjoni lill-Kummissjoni, lill-Istati Membri u lillpubbliku in ġenerali
English: To be released for public consultation by Q4 2005
Maltese: Għandha tinħareġ għal konsultazzjoni pubblika sa t-tieni kwart ta' l-2005
English: Main CHMP standing and temporary working parties in 2005
Maltese: Gruppi ta' ħidma ewlenin tal-CHMP, permanenti u temporanji fl-2005
English: Increase in workload as a result of the EU enlargement (handling of product information in 20 EU languages and possibility for additional referral procedures) and Commission decisions which involve specific commitments (pre-clinical trials, clinical trials, PSURs, post-marketing studies, registries) that need adequate follow-up
Maltese: Żieda fl-ammont tax-xogħol bħala riżultat tat-tkabbir ta' l-UE (l-immaniġjar ta' informazzjoni dwar il-prodotti f'20 lingwa ta' l-UE u l-possibiltà ta' proċeduri addizzjonali ta' referenza) u deċiżjonijiet tal-Kummissjoni li jinvolvu impenni speċifiċi (provi pre-kliniċi, provi kliniċi,
English: To provide quality opinions during post-authorisation activities adhering to regulatory timelines and to communicate post-authorisation information to interested parties The performance indicator for this objective is the percentage of applications evaluated within the 30, 60 or 90-day timeline (depending on the procedure).
Maltese: L-Indikatur ta' prestazzjoni għal din il-mira huwa l-perċentwali ta' applikazzjonijiet ivvalutati fillimitu ta' żmien ta' 30, 60 jew 90 jum (skond il-proċedura).
English: The EMEA coordinates the verification of compliance with the principles of Good Manufacturing Practice (GMP), Good Clinical Practice (GCP) and Good Laboratory Practice (GLP), and with certain aspects of the supervision of authorised medicinal products in use in the European Community, through inspections requested by the CHMP or CVMP in connection with the assessment of marketing authorisation applications and/or the assessment of matters referred to these committees in accordance with Community legislation.
Maltese: L-EMEA tikkoordina l-verifika ta' konformità mal-prinċipji ta' Prattika Tajba ta' Manifattura (GMP), Prattika Klinika Tajba (GCP), u Prattika Tajba tal-Laboratorju (GLP), u ma' ċerti aspetti tassorveljanza ta' prodotti mediċinali awtorizzati għall-użu fil-Komunità Ewropea, permezz ta'
English: 6.3 EMEA document management and publishing
Maltese: 6.3 Il-Ġestjoni u l-pubblikazzjoni ta' dokumenti ta' l-EMEA
English: He joined the EMEA in May 1999 and one of his major activities in recent years was the establishment of orphan drug designation and protocol assistance in the EMEA.
Maltese: l-1999 u waħda mill-attivitajiet principali tiegħu fi snin riċenti kienet it-twaqqif ta' l-ikklassifikar ta' mediċini ltiema u assistenza għall-protokoll fl-EMEA.
English: The certification of these Master Files in a system analogous to the centralised procedure leads to the issuance by the EMEA of a certificate of compliance with Community legislation that is valid throughout the European Community.
Maltese: Iċ-ċertifikazzjoni ta' dawn il-Fajls Prinċipali f'sistema analoga għall-proċedura ċentralizzata twassal għall-ħruġ mill-EMEA ta' ċertifikat ta' konformità mal-leġislazzjoni Komunitarja li huwa validu fil-Komunità Ewropea kollha.
English: The trend in applications through the centralised procedure continues, ensuring a steady supply of new and innovative medicines for veterinarians and animal owners throughout the Community
Maltese: Tkompli x-xejra f'applikazzjonijiet permezz tal-proċedura ċentralizzata, biex b'hekk hija assigurata fornitura kontinwa ta' mediċini ġodda u innovattivi għall-veterinarji u s-sidien ta' l annimali fil-Komunità kollha
English: The special Community fund (‘orphan drug fund') supports additional new applications and protocol assistance, as well as the post-authorisation activities that are necessary due to the increasing number of orphan medicinal products with Community marketing authorisations.
Maltese: Il-fond Komunitarju speċjali (‘il-fond għal mediċini ltiema') isostni applikazzjonijiet addizzjonali ġodda u assistenza għall-protokoll, kif ukoll l-attivitajiet ta' wara l-awtorizzazzjoni li huma neċessarji minħabba n-numru dejjem jiżdied ta' prodotti mediċinali ltiema b'awtorizzazzjonijiet Komunitarji għal tqegħid fis-suq.
English: In 2005, particular emphasis will be placed on preparations for the full mandate of the Committee.
Maltese: Fl-2005, ikun hemm emfasi partikolari fuq il-preparazzjoni għall-mandat sħiħ tal-Kumitat.
English: CHMP Guideline on handling direct healthcare professional communication for medicinal products for human use
Maltese: CHMP Guideline on Risk Assessment of Medicinal Products on Human
English: Support the implementation activities relating to GCP inspections under the Clinical Trials Directive 2001/20/EC for human medicines and the directive on GCP, in particular the implementation of the second phase of the EudraCT database
Maltese: taħt id-Direttiva dwar il-provi kliniċi 2001/20/KE għal mediċini għall-użu tal-bniedem u ddirettiva dwar il-GCP, u b'mod partikolari l-implimentazzjoni tat-tieni fażi tal-bażi tad-data EudraCT
English: The EMEA will provide support to workshops with stakeholders, in particular with academic research organisations, organised at the initiative of the COMP and CHMP, on new scientific and methodological aspects.
Maltese: L-EMEA tipprovdi sostenn għal workshops ma' partijiet interessati, b'mod partikolari ma' organizzazzjonijiet akkademiċi ta' riċerka, organizzati fuq l-inizjattiva tal-COMP u tal-CHMP, dwar aspetti ġodda xjentifiċi u metodoloġiċi.
English: 2.3 Initial evaluation
Maltese: 2.3 Valutazzjoni inizjali
English: 2.5 Pharmacovigilance and maintenance activities 2.6 Arbitration and Community referrals 2.7 Herbal medicinal products
Maltese: 2 MEDIĊINI GĦALL-UŻU TAL-BNIEDEM 2.1 Prodotti mediċinali iltiema 2.2 Pariri xjentifiċi u assistenza għall-protokoll 2.3 Valutazzjoni inizjali
English: The legislation allows the committees to establish scientific advisory groups in connection with the evaluation of specific types of pharmaceutical products or treatments.
Maltese: Il-Leġislazzjoni tippermetti lill kumitati jistabilixxu gruppi xjentifiċi konsultattivi in konnessjoni mal-valutazzjoni ta' tipi speċifiċi ta' prodotti farmaċewtiċi jew trattamenti.
English: Objectives:
Maltese: Definitions and
English: In 1984, he joined the Veterinary Medicines Laboratory in Fougères where he was assessor and rapporteur for marketing authorisation dossiers.
Maltese: Fl-1984, ingħaqad mal-Laboratorju ta' Mediċini Veterinarji f'Fougères fejn kien valutatur u rapportatur għal applikazzjonijiet għall-awtorizzazzjoni għal tqegħid fis-suq.
English: For matters relating to pharmacovigilance for
Maltese: Pharmacovigilance for Vaccines
English: Studies and consultants Publications
Maltese: informazzjoni lill-pubbliku
English: From 1984 to 1994, as medical director at the pharmaceutical department of the Italian Ministry of Health, she was in charge of the Operative Centre for Community Procedures, was the Italian member of the former Committee for Proprietary Medicinal Products (CPMP), and was also involved in ICH activities.
Maltese: 1994, bħala direttur mediku fid-Dipartiment Farmaċewtiku tal-Ministeru tas-Saħħa Taljan, kienet inkarigata miċ-Ċentru operattiv għal Proċeduri Komunitarji u kienet membru Taljan ta' dak li qabel kien il-Kumitat għal Prodotti Mediċinali Propjetarji (CPMP) u kienet ukoll involuta f'attivitajiet ta' lICH.
English: PhD in organic chemistry from the Free University of Berlin.
Maltese: Kimiku u spiżjara kkwalifikata mill-Università Ħielsa ta' Berlin, PhD fil-kimika organika mill-Università Ħielsa ta' Berlin.
English: HMPC meetings in 2005
Maltese: Laqgħat ta' l-HMPC fl-2005
English: The working party will develop a technical guidance document prepared in cooperation with Member States and industry to facilitate implementation of the CVMP/VICH guideline.
Maltese: Il-Grupp ta' Ħidma jiżviluppa dokument ta' gwida teknika ppreparat f'kooperazzjoni ma' l-Istati Membri u l industrija sabiex jiffaċilita l-implimentazzjoni tal-linja gwida CVMP/VICH.
English: 3 VETERINARY MEDICINES 3.1 Scientific advice
Maltese: 2.12 Il-Grupp ta' koordinazzjoni 3 MEDIĊINI VETERINARJI 3.1 Pariri xjentifiċi
English: Following a very useful exchange of views in 2004 with IFAH-Europe, the procedure and guidance for prospective applicants to request scientific advice have been considerably amended.
Maltese: Wara skambju utli ħafna ta' opinjonijiet fl-2004 ma' l-IFAH-Ewropa, il-proċedura u l-gwida sabiex applikanti prospettivi jitolbu parir xjentifiku ġew emendati konsiderevolment.
English: The table below gives an overview of the likely workload in accounts in 2005.
Maltese: In-numru ta' applikazzjonijiet inizjali għal awtorizzazzjoni għal tqegħid fis-suq huwa mistenni jistabilizza ruħu fl-2005.
English: The performance indicator for this objective is the percentage of applications evaluated within the 30, 60 or 90-day timeline (depending on the procedure).
Maltese: L-Indikatur ta' prestazzjoni għal din il-mira huwa l-perċentwali ta' applikazzjonijiet ivvalutati fil-limitu ta' żmien ta' 30, 60 jew 90 jum (skond il-proċedura).
English: Provision of accurate and timely financial information to management Implementation of inventory accounting system
Maltese: Il-Provviżjoni ta' informazzjoni finanzjarja preċiża u f'waqtha lid-diriġenti L-Implimentazzjoni ta' sistema inventarja ta' kontabilità
English: Postgraduate degree in pharmacology; associate professor in pharmacology and toxicology at the University of Vienna.
Maltese: Lawrea post-universitarja fil farmakoloġija, Professur Assoċjat tal-farmkoloġika u t-tossikoloġija fl-Università ta' Vjenna.
English: Some 18,800 adverse drug reaction (ADR) reports for centrally authorised medicines are expected to be received by paper mail for EU cases, with an additional 3,390 ADR reports from outside the EU
Maltese: Hu mistenni li jaslu bil-posta xi 18,800 rapport ta' reazzjoni mhux mixtieqa għal mediċini
English: Education: Master's degree in pharmacy and doctor of natural sciences degree in pharmacology from the University of Vienna.
Maltese: Lawrea ta' Masters fil-farmaċija u Lawrea ta' Dottorat ta' Xjenzi Naturali fil farmakoloġija mill-Università ta' Vjenna.
English: The new requirements include the establishment of procedures for conditional marketing authorisations, accelerated assessment, compassionate use and for opinions on medicinal products intended for markets exclusively outside the EU (in collaboration with the WHO).
Maltese: Il-ħtiġijiet ġodda jinkludu t-tħejjija ta' proċeduri għal awtorizzazzjonijiet kondizzjonali għal tqegħid fis-suq, valutazzjoni mgħaġġla, użu kompassjonali u għal opinjonijiet dwar prodotti mediċinali maħsuba għal swieq esklużivament barra l-UE (f'kollaborazzjoni mal-WHO).
English: In order to meet expectations from sponsors and patient organisations, and taking into account the level of the orphan drug fund, it is proposed, in line with recommendations of the Committee on Orphan Medicinal Products (COMP), that the level of fee reductions provide a maximum incentive during the development and registration phase, and should cover:
Maltese: Sabiex jintlaħħqu l-istennijiet ta' sponsors u organizzazzjonijiet tal-pazjenti, u filwaqt li jittieħed in konsiderazzjoni il-livell tal-fond għal mediċini ltiema, huwa propost, in linja marrakkomandazzjonijiet tal-Kumitat dwar Prodotti Mediċinali Ltiema (COMP), li l-livell ta' tnaqqis ta'
English: To be re-released for consultation in 4Q 2004/1Q 2005
Maltese: Għandha tinħareġ għal konsultazzjoni fl-ewwel/tieni kwart ta' l-2005
English: Establishment of the necessary measures to provide assistance to companies producing veterinary products which have limited markets or are intended for diseases with a regional distribution (Article 79 of Regulation 726/2004)
Maltese: It-Teħid tal-miżuri neċessarji sabiex tiġi pprovduta assistenza lil kumpanniji li jipproduċu prodotti veterinarji li għandhom swieq limitati jew huma maħsuba għal mard b'distribuzzjoni reġjonali (l-Artikolu 79 tar-Regolament 726/2004)
English: 3.2 Initial evaluation
Maltese: 3.2 Valutazzjoni inizjali
English: The target is 100 % of summaries published at the time of the press release o percentage of MRL summary reports published within 14 days after publication of Community MRLs.
Maltese: Il-mira hija 100% tal-ġabriet fil-qosor ippubblikati fil-ħin ta' l-istqarrija għall-istampa o il-perċentwali ta' rapporti fil-qosor ta' l-MRL ippubblikati fi żmien 14-il jum wara lpubblikazzjoni ta' MRL Komunitarji.
English: There is only limited market growth foreseen in the veterinary pharmaceutical sector as a result of a reduction in the number of companies and industry's claims that investment in new products is being diverted into defensive research and development
Maltese: Hemm biss previst tkabbir limitat fis-suq tas-settur farmaeċewtiku veterinarju bħala riżultat ta' tnaqqis fin-numru ta' kumpanniji u tad-dikjarazzjonijiet mill-industrija li nvestiment fi prodotti ġodda qiegħed jiġi ddevjat lejn riċerka u żvilupp ta' natura difensiva
English: To be released in 1Q 2005
Maltese: CHMP sa t-tieni kwart ta' l-2005
English: He was re-elected vice-chairman of the CVMP in 2004.
Maltese: Reġa' inħatar viċi-president tal-CVMP fl-2004.
English: Education: Qualified pharmacist and degree in medicine and surgery from the University of Barcelona, as well as postgraduate courses in pharmacology and toxicology, public health and European institutions.
Maltese: Barċellona kif ukoll korsijiet post universitarji fil-farmakoloġija u fit-tossikoloġija, fis-saħħa pubblika u istituzzjonijiet Ewropej.
English: Following the first PMF applications received in 2004, seven applications are forecast for 2005.
Maltese: Wara l-ewwel applikazzjonijiet PMF riċevuti fl-2004, huma mbassra seba' applikazzjonijiet għall-2005.